TRIFLURIDINE AND TIPIRACIL

10823 reported adverse events

Drug classes: Nucleoside Analog Antiviral [EPC] Nucleoside Metabolic Inhibitor [EPC]

These side effects are most commonly reported by patients taking TRIFLURIDINE AND TIPIRACIL:

# Side effect Count
0 DEATH 3101
1 DISEASE PROGRESSION 1795
2 FATIGUE 1435
3 NAUSEA 1202
4 DIARRHOEA 1040
5 DECREASED APPETITE 695
6 VOMITING 649
7 ASTHENIA 510
8 WHITE BLOOD CELL COUNT DECREASED 500
9 ANAEMIA 375
See all common reactions for TRIFLURIDINE AND TIPIRACIL

TRIFLURIDINE AND TIPIRACIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIAPHRAGMATIC OPERATION 6 0.1818
1 COLORECTAL CANCER RECURRENT 7 0.0543
2 RECTAL CANCER METASTATIC 16 0.0460
3 COLORECTAL CANCER METASTATIC 77 0.0325
4 CARCINOEMBRYONIC ANTIGEN INCREASED 50 0.0258
5 STOMA SITE HAEMORRHAGE 30 0.0195
6 COLON CANCER METASTATIC 28 0.0174
7 BLOOD ALKALINE PHOSPHATASE ABNORMAL 15 0.0167
8 DISEASE PROGRESSION 1795 0.0152
9 CYTOPENIA 180 0.0147
See all enriched reactions for TRIFLURIDINE AND TIPIRACIL